Related Experiment Video
Updated: Feb 27, 2026
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
[Molecular background of the melanoma and the brain metastasis]
Frida Katona1, Balázs Murnyák1, György Marko-Varga2
1Patológiai Intézet, Neuropatológiai Tanszék, Debreceni Egyetem, Általános Orvostudományi Kar Debrecen, Nagyerdei krt. 98., 4032.
Abstract:
Malignant melanoma is one of the most aggressive tumors which often gives metastasis to distant organs thereby limiting the chances of survival. Brain metastasis occurs in nearly half of the advanced tumors. In order to improve outcome early diagnosis is important. The discovery and better understanding of genetic and epigenetic changes is essential for developing new effective therapies, which can designate promising therapeutic targets. Melanoma most often is caused by gene mutations of the mitogen-activated protein kinase pathway, the phosphatidylinositol 3-kinase signaling pathway, and the cell cycle regulatory molecules, respectively. The molecular process of brain metastasis has not been fully elucidated. In our review we summarize the genetic alterations and molecular mechanisms playing a role in the development of melanoma and its brain metastasis. Orv Hetil. 2017; 158(28): 1083-1091.
Insights
Understanding genetic and epigenetic changes in malignant melanoma is crucial for early diagnosis and effective therapies. This review summarizes key molecular mechanisms driving melanoma and its brain metastasis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Malignant melanoma is an aggressive cancer with high rates of metastasis, particularly to the brain, significantly reducing survival.
- Early diagnosis and targeted therapies are vital for improving patient outcomes in advanced melanoma.
- Current understanding of melanoma's molecular progression and brain metastasis mechanisms requires further elucidation.
Purpose of the Study:
- To review and summarize the genetic alterations and molecular mechanisms involved in melanoma development.
- To elucidate the molecular processes underlying melanoma's brain metastasis.
- To identify potential therapeutic targets for melanoma treatment.
Main Methods:
- Literature review of genetic and epigenetic changes in melanoma.
- Analysis of molecular pathways implicated in melanoma progression.
- Synthesis of current knowledge on melanoma brain metastasis mechanisms.
Main Results:
- Melanoma is frequently driven by mutations in the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) signaling pathways.
- Alterations in cell cycle regulatory molecules also contribute to melanoma pathogenesis.
- The specific molecular events leading to brain metastasis are not fully understood but involve complex genetic and epigenetic factors.
Conclusions:
- A comprehensive understanding of genetic and epigenetic alterations is essential for developing novel therapeutic strategies against melanoma.
- Further research into the molecular mechanisms of brain metastasis is needed to improve treatment efficacy.
- Identifying promising therapeutic targets through molecular insights can enhance survival rates for melanoma patients.
